Cash Flow Towa Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
13,165.00
26,330.00
24,459.00
4,605.00
22,246.00
18,728.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-6,559.00
-10,530.00
-26,944.00
-16,829.00
-3,363.00
-13,311.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
30,429.00
23,401.00
8,212.00
2,544.00
22,129.00
12,008.00
Cash Flow from Investing Activities
-25,660.00
-31,287.00
-40,394.00
-30,284.00
-59,729.00
-9,100.00
Cash Flow from Financing Activities
-6,828.00
21,567.00
35,407.00
17,481.00
46,540.00
184.00
Net Cash Inflow / Outflow
-649.00
15,597.00
5,392.00
-8,574.00
9,915.00
3,853.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1,410.00
1,916.00
2,167.00
1,685.00
975.00
761.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Towa Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
13165
19435
-6,270.00
-32.26%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-6559
6758
-13,317.00
-197.06%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
30429
29780
649.00
2.18%
Cash Flow from Investing Activities
-25660
-19650
-6,010.00
-30.59%
Cash Flow from Financing Activities
-6828
-5369
-1,459.00
-27.17%
Net Cash Inflow / Outflow
-649
4761
-5,410.00
-113.63%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1410
0
1,410.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 30.03% vs 184.96% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
30,429.00
23,401.00
30.03%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
